Kinaxis is fully valued, Industrial Alliance says

Expect longer term growth from cloud-based supply chain software company Kinaxis (Kinaxis Stock Quote, Chart, News: TSX:KXS), says Blair Abernethy of Industrial Alliance Securities, who in a research update to clients on Tuesday maintained his ”Hold” rating and $83.00 price target.

Kinaxis held its annual Investor Day on Tuesday morning, with emphasis reportedly being placed on expanding the company’s sales team by 40 per cent this year, particularly in the European and Asian markets.

Abernethy says that Kinaxis seems to be attracting more partners as more and more companies learn about its products.

“Kinaxis remains focussed on six key verticals and is approximately 35-40 per cent penetrated in its customer ~100 base,” says the analyst. “Management noted interest in the food/beverage vertical and process industries (likely but longer term). Our take: Kinaxis is steadily moving beyond the early adopter stage as interest in their solution is broadening. New customers are key to faster revenue growth as ~35-40 per cent installed-base penetration is fairly high in our opinion.”

“We came away incrementally positive on the stock as the longer term growth profile, given sales investment, partners, and potential for vertical expansion, looks to have an upward bias. However, at stock price current levels, we are maintaining our Hold rating,” says the analyst.

The analyst thinks KXS will see revenue and EBITDA in 2018 of $159.7 million and $40.7 million, respectively, and a topline and EBITDA of $197.3 million and $54.3 million, respectively, in 2019.

Abernethy’s $83.00 target price represents a 0.0 per cent return on investment as of publication date.

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: kxs
Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

Is Peloton Stock a Buy? (May, 2024)

Following news of a restructuring, Roth MKM analyst George Kelly has chopped his price target on Peloton (Peloton Stock Quote,… [Read More]

2 days ago

Is Ascend Wellness stock a buy?

Ahead of the company's first quarter results, Beacon analyst Russell Stanley thinks Ascend Wellness (Ascend Wellness Stock Quote, Chart, News,… [Read More]

2 days ago

Paradigm chops price target on Snipp Interactive

Following the company's fourth quarter results, Paradigm Capital analyst Daniel Rosenberg has cut his price target on Snipp Interactive (Snipp… [Read More]

2 days ago

It’s time to buy cannabis stocks, this analyst says

A major development came down the pipe this week at the U.S. Drug Enforcement Agency has reportedly decided to reschedule… [Read More]

3 days ago

Is Generac stock a buy?

Following the company's first quarter results, Roth MKM analyst Chip Moore remains neutral on Generac Holdings (Generac Holdings Stock Quote,… [Read More]

3 days ago

Bombardier is a buy, Desjardins says (May, 2024)

The stock has climbed slowly but surely since last October. But is there still money to be made on Bombardier?… [Read More]

3 days ago